Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients With Known or Suspected Focal Liver Lesions and Severe Renal Impairment

NCT04119843 is registered in ClinicalTrials.gov with Ascelia Pharma AB as lead sponsor.

NCT NCT04119843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients With Known or Suspected Focal Liver Lesions and Severe Renal Impairment
Lead sponsor
Ascelia Pharma AB
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2020
Completion date
February 17, 2023
Enrollment
87 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

known or suspected focal liver lesions, severe renal impairment